In the Lab
By Julie Grisham, MS, Science Writer/Editor | Friday, January 20, 2012
Infections are a common cause of complications in cancer patients. Now a Memorial Sloan Kettering research team finds that a commonly prescribed antibiotic could increase susceptibility to a bacterial infection.
By Memorial Sloan Kettering | Thursday, January 19, 2012
When actor Michael Quinlan was diagnosed with prostate cancer, he came to Memorial Sloan Kettering to learn about treatment options from our multidisciplinary team of experts. After undergoing robot-assisted laparoscopic surgery, he remains cancer-free.
By Memorial Sloan Kettering | Tuesday, January 17, 2012
The Spine Tumor Center at Memorial Sloan Kettering provides state-of-the-art diagnostic and treatment services for more than 1,500 people with primary or metastatic spine tumors each year.
In the Clinic
By Media Staff | Friday, January 13, 2012
Researchers at Memorial Sloan Kettering have shown the usefulness of a scale called the Bone Scan Index (BSI) for determining whether some prostate cancer patients are responding to therapy.
By Julie Grisham, MS, Science Writer/Editor | Wednesday, December 28, 2011
Years of innovative research, technology development, and facility expansion at Memorial Sloan Kettering have led to several new experimental treatments for people with cancer.
By Craig Thompson, MD, President and CEO | Friday, December 23, 2011
Since the signing of the National Cancer Act in 1971, tremendous progress has been made in preventing and treating cancer—though challenges remain.
In the News
By Media Staff | Thursday, December 22, 2011
After signing up for the National Bone Marrow Registry “Be The Match,” a Montclair man was recently called to donate peripheral blood stem cells for a sick child. He was inspired to join the registry after an anonymous donor saved the life of his own son, who had received a bone marrow transplant.
By Memorial Sloan Kettering | Wednesday, December 21, 2011
As a tribute to Memorial Sloan Kettering Board member Josephine “Josie” Robertson, Memorial Sloan Kettering has joined with The Robertson Foundation to undertake two high-profile initiatives — the Josie Robertson Surgery Center and the Josie Robertson Investigators Program — made possible by a $50 million commitment from The Robertson Foundation.
By Jim Stallard, MA, Writer/Editor | Tuesday, December 20, 2011
German-born cancer biologist Hans-Guido Wendel is taking advantage of transformative advances in genomics technology to understand key genetic abnormalities in leukemia and lymphoma.
In the Clinic
By Eva Kiesler, PhD, Science Writer/Editor | Monday, December 19, 2011
People with cancer of the nasopharynx, an area behind the nose, may benefit from a new combination therapy, according to an international study led by Memorial Sloan Kettering radiation oncologist Nancy Y. Lee.
By Eva Kiesler, PhD, Science Writer/Editor | Thursday, December 15, 2011
Memorial Sloan Kettering scientists, physicians, and administrators are developing and commercializing research discoveries to generate more-effective and affordable cancer treatments.
By Media Staff | Wednesday, December 14, 2011
Five Memorial Sloan Kettering scientists have been appointed to a new research team dedicated to identifying targets for therapies to treat a certain form of melanoma.
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor | Tuesday, December 13, 2011
Scientists have generated a compound that could potentially be used to create a new type of pain medication that may prevent the side effects of currently available painkillers.
In the Lab
By Julie Grisham, MS, Science Writer/Editor | Monday, December 12, 2011
A Memorial Sloan Kettering study suggests that a new, experimental treatment could make bone marrow and stem cell transplantation safer and more effective.
By Memorial Sloan Kettering | Wednesday, December 7, 2011
Memorial Sloan Kettering medical oncologist Clifford A. Hudis has been elected President of the American Society of Clinical Oncology, the world’s leading professional organization representing more than 30,000 physicians who care for people with cancer.